Compare SENS & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SENS | TLRY |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 496.0M | 560.3M |
| IPO Year | 2014 | 2018 |
| Metric | SENS | TLRY |
|---|---|---|
| Price | $10.44 | $4.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $18.38 | ★ $72.33 |
| AVG Volume (30 Days) | 573.7K | ★ 3.2M |
| Earning Date | 05-08-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.69 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,389,000.00 | N/A |
| Revenue This Year | $74.15 | $8.79 |
| Revenue Next Year | $58.60 | $19.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.85 | N/A |
| 52 Week Low | $0.41 | $0.77 |
| 52 Week High | $10.15 | $15.70 |
| Indicator | SENS | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 67.92 | 42.66 |
| Support Level | $8.45 | $3.87 |
| Resistance Level | $10.07 | $4.91 |
| Average True Range (ATR) | 0.45 | 0.15 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 95.03 | 33.58 |
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.